Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2020

Open Access 01-12-2020 | Correction

Correction to: Association of dietary inflammatory potential with cardiometabolic risk factors and diseases: a systematic review and dose–response meta-analysis of observational studies

Authors: Zahra Aslani, Omid Sadeghi, Motahar Heidari-Beni, Hoda Zahedi, Fereshteh Baygi, Nitin Shivappa, James R. Hébert, Sajjad Moradi, Gity Sotoudeh, Hamid Asayesh, Shirin Djalalinia, Mostafa Qorbani

Published in: Diabetology & Metabolic Syndrome | Issue 1/2020

Login to get access

Excerpt

It was highlighted that in the original article, the Funding section statement was incorrect. This Correction article shows the incorrect and correct Funding section statement. The original article has been updated. …
Literature
1.
Metadata
Title
Correction to: Association of dietary inflammatory potential with cardiometabolic risk factors and diseases: a systematic review and dose–response meta-analysis of observational studies
Authors
Zahra Aslani
Omid Sadeghi
Motahar Heidari-Beni
Hoda Zahedi
Fereshteh Baygi
Nitin Shivappa
James R. Hébert
Sajjad Moradi
Gity Sotoudeh
Hamid Asayesh
Shirin Djalalinia
Mostafa Qorbani
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2020
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-020-00615-2

Other articles of this Issue 1/2020

Diabetology & Metabolic Syndrome 1/2020 Go to the issue

Short report

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment

Short report

Increased leukotriene B4 plasma concentration in type 2 diabetes individuals with cardiovascular autonomic neuropathy

Commentary

Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?

Research

Association of [1H]-MRS quantified liver fat content with glucose metabolism status

Research

The potential therapeutic effects of Lactobacillus plantarum and inulin on serum and testicular reproductive markers in diabetic male rats

Review

Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits